MAR 06, 2020 9:07 PM PST

Drug Improves Cancer Therapy

WRITTEN BY: Nouran Amin

Prochlorperazine (PCZ) is a drug used for psychiatric use and the therapeutic treatment of nausea but was recently found to block the internalization of molecular receptors on the surface of tumor cells allowing more effective anticancer antibodies to avoid immune evasion.

"This represents a potentially disruptive change in clinical approaches to improve therapeutic targeting as the opportunity of temporarily moving drug targets within patient tumor cells becomes possible," says senior author Fiona Simpson, a cancer researcher at the University of Queensland.

PCZ was used as the temporary treatment of cancer in some patients and results yielded receptor clustering inside cancer cells of patients. Findings were published in the journal Cell.

"These findings highlight the crucial role of availability and persistence of the molecule targeted by the therapeutic antibody at the cell surface of tumor cells," Simpson says.

PCZ is also used in laboratory studies to inhibit a cellular process known as endocytosis—a mechanism that brings outside substances to the inside of the cell. Such inhibition has held clinical relevance for the control of viral infection.

Learn more about endocytosis:

To apply the mechanisms of PCZ, researchers analyzed tumor samples from patients and found a decrease in endocytosis of a protein known as epidermal growth factor receptor (EGFR). The particular protein was found to be inhibited by a cancer therapeutic called cetuximab.

"We found that if we stopped the drug targets getting inside the cells by inhibiting the uptake process, called endocytosis, we got a really big immune response against the tumors in mice," Simpson says. "This led to the concept that temporarily halting endocytosis of receptors that are the targets of monoclonal antibody therapies may be used to improve clinical outcomes.”

Source: Science Daily

About the Author
Master's (MA/MS/Other)
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
NOV 23, 2022
Drug Discovery & Development
Evidence of antibiotic resistance genes in 'zombie' microbes of the arctic permafrost
Evidence of antibiotic resistance genes in 'zombie' microbes of the arctic permafrost
One of the most significant consequences of climate change is the greenhouse gases generated from the microbial decompos ...
DEC 19, 2022
Cancer
TIL Therapy for Advanced Melanoma Extends Survival Over Ipilimumab
TIL Therapy for Advanced Melanoma Extends Survival Over Ipilimumab
Immune checkpoint inhibitors (ICIs) have become a treatment option for many patients with advanced melanoma.  Still ...
DEC 27, 2022
Drug Discovery & Development
Blood Pressure Drug and Antioxidant May Treat Long COVID Brain Fog
Blood Pressure Drug and Antioxidant May Treat Long COVID Brain Fog
Two FDA-approved drugs mitigate and may even eliminate brain fog in people with long COVID. The corresponding case repor ...
JAN 05, 2023
Health & Medicine
Potential Over-the-Counter Access to Naloxone- a life saving drug
Potential Over-the-Counter Access to Naloxone- a life saving drug
Naloxone is a powerful FDA-approved opioid antagonist that works to reverse life-threatening opioid overdoses. Sinc ...
DEC 30, 2022
Health & Medicine
Individuals in Mid-Adulthood Sleep Less Than Younger and Older Adults
Individuals in Mid-Adulthood Sleep Less Than Younger and Older Adults
A study published in Nature Communications found that people sleep less on average in mid-adulthood than in early and la ...
JAN 23, 2023
Neuroscience
Tau tangles unravel when these three genes are silenced
Tau tangles unravel when these three genes are silenced
By controling the activity of an enzyme called CHIP, three proteins regulate tau. Now the genes for these three trouble ...
Loading Comments...